Results 121 to 130 of about 5,729,296 (288)

NEEDED RESEARCH WITH RESPECT TO ENERGY USE IN AGRICULTURAL PRODUCTION [PDF]

open access: yes
Resource /Energy Economics and Policy,
Capps, Oral, Jr., Havlicek, Joseph, Jr.
core   +1 more source

Onasemnogene Abeparvovec in Type I Spinal Muscular Atrophy: 24‐Month Follow‐Up From the Italian Registry

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane   +43 more
wiley   +1 more source

THE DEMAND FOR GASOLINE AND DIESEL FUEL IN AGRICULTURAL USE IN VIRGINIA [PDF]

open access: yes
Resource /Energy Economics and Policy,
Capps, Oral, Jr., Havlicek, Joseph, Jr.
core   +1 more source

A Depolarizing Leak in Sodium Bicarbonate Cotransporter NBCe1 Causes Brain Edema

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives SLC4A4 encodes electrogenic sodium bicarbonate cotransporter NBCe1, prominently expressed in kidney and brain. Recessive loss‐of‐function variants in SLC4A4 cause proximal renal tubular acidosis, no brain edema. In the brain, NBCe1 is expressed by astrocytes, where it regulates pH and mediates astrocyte volume changes.
Quinty Bisseling   +16 more
wiley   +1 more source

Measuring the Effectiveness of Lamb Advertising and Promotion: An Updated Analysis [PDF]

open access: yes
This report updates a previous tentative analysis of the effectiveness of the Lamb Checkoff Program in shifting out the demand for American lamb. The main conclusion is that program has resulted in roughly 8.4 additional pounds of total lamb consumption ...
Capps, Oral, Jr., Williams, Gary W.
core   +1 more source

ALDOA Promotes Glycolysis and NLRP3/GSDMD Pyroptosis to Accelerate ALS Progression

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Amyotrophic lateral sclerosis (ALS) is characterized by progressive motor neuron degeneration. Glycolytic dysregulation is implicated in disease progression, yet the underlying mechanisms remain unclear. This study investigates how Aldolase A (ALDOA) drives ALS progression through glycolysis‐mediated motor neuron pyroptosis.
Kaixin Yan   +9 more
wiley   +1 more source

Adverse events in different administration routes of amiodarone: a pharmacovigilance study based on the FDA adverse event reporting system

open access: yesFrontiers in Pharmacology
BackgroundArrhythmias are prevalent cardiac disorders with significant impacts on patient quality of life and mortality. Amiodarone, a class III antiarrhythmic agent, is widely used to manage both atrial and ventricular arrhythmias due to its efficacy in
Jingrong Yang   +10 more
doaj   +1 more source

Measuring the Effectiveness of Checkoff Programs [PDF]

open access: yes
Marketing, Q13, M31, M37,
Capps, Oral, Jr., Williams, Gary W.
core   +1 more source

[18F]Fluorodeprenyl‐D2 PET as a Tool to Monitor Disease Activity in GAD65‐Ab Autoimmune Encephalitis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate [18F]fluorodeprenyl‐D2 ([18F]F‐DED) positron‐emission tomography (PET) imaging as a biomarker of disease activity in autoimmune encephalitis (AIE) associated with glutamic acid decarboxylase 65 (GAD65) antibodies. Methods [18F]F‐DED PET was performed in 25 GAD65‐AIE patients and 8 controls using dynamic (0–60 min) and ...
Julia S. Dorneich   +19 more
wiley   +1 more source

Building Up a Real Sector Business Confidence Index for Turkey [PDF]

open access: yes
The two major aims of this study are, firstly, to receive valuable insight into the Business Tendency Survey of the Central Bank of the Republic of Turkey and, secondly, to construct a real sector confidence index by using the questions of the Business ...
Dilara Ece, Ece Oral, Turknur Hamsici
core  

Home - About - Disclaimer - Privacy